Background
==========

Leptospirosis is a globally important zoonotic disease caused by pathogenic *Leptospira*species\[[@B1]\]. Leptospires are thin, helically coiled, motile bacteria, classified into 17 genomospecies (including the saprophyte *Leptospira biflexa*and the pathogen *Leptospira interrogans*) on the basis of DNA-DNA hybridization studies, or serologically classified into more than two hundred pathogenic serovars on the basis of structural heterogeneity in the carbohydrate component of the lipopolysaccharide\[[@B2],[@B3]\]. Currently available vaccines, based on inactivated whole bacteria or membrane preparations from pathogenic leptospires, are of low efficacy, have an unacceptable side-effect profile, require annual booster immunizations and do not confer cross-protective immunity against different serovars \[[@B4]-[@B6]\]. Because of these concerns, the current major focus in leptospirosis research is to discover cross-species-conserved or cross-serovar-conserved protective antigens that may elicit longer-term protection against a broad range of *Leptospira*\[[@B5],[@B7]\]. New vaccine development strategies are thus needed for preventing this zoonosis. Reverse vaccinology, which based on the genomic approach, has been applied to some bacteria, and novel vaccine candidate sequences have been identified \[[@B8]-[@B11]\]. The genome projects of two *Leptospira*strains give us intensive knowledge on the whole genome level \[[@B12]-[@B14]\]. Although many efforts have been made to identify the surface-exposed proteins of leptospires, finding perfect vaccine candidate antigens that provide cross-protection against different serovars of pathogenic *L. interrogans*still requires further work\[[@B7],[@B15]-[@B17]\].

In our current study, we identified 226 potential candidate vaccine genes against *L. interrogans*using *in silico*analysis, comparative genomic hybridization (CGH) and transcriptional analysis, based on a genome-wide DNA microarray comprising 3528 open reading frames (ORFs) derived from the original annotation of *L. interrogans*strain \#56601. These candidate genes not only encode surface-exposed proteins of *L. interrogans*strain \#56601, but also have high transcription levels *in vitro*. Moreover, the proteins encoded by these genes are conserved in two sequenced *L. interrogans*and ten epidemic pathogenic serovars in China.

Results
=======

*In silico*analysis for identification of genes encoding surface-exposed proteins
---------------------------------------------------------------------------------

In 4727 ORFs of *L. interrogans*strain \#56601, 1282 proteins were predicted to be surface-exposed using P-CLASSIFIER, 654 proteins had signal peptides, 813 were predicted to have no more than four α-helices with transmembrane topology, 96 were predicted to have β-barrel topology implying that they are integral β-barrel outer membrane proteins, and 158 were predicted have a lipoprotein signal peptide using SpLiP. The number of genes in the intersection between the set of surface-exposed proteins identified by P-CLASSIFIER and the set of proteins characterized by at least one of the four characteristic topologies is 688. We calculated the similarity of proteins between serovar Lai and serovar Copenhageni as well as between serovar Lai and human (cut-off value: similarity \>70% and E value = 1e-10 for two serovars, E value = 1e-10 for serovar Lai and human) using BLASTP. We found 3672 orthologs between the two serovars, and 605 proteins that are similar in serovar Lai and human. Finally, 616 genes were yielded by the bioinformatics study by retaining the orthologs between the two serovars and subtracting the genes that were similar in serovar Lai and human.

Comparative genomic hybridization
---------------------------------

We prepared a gene chip microarray corresponding to the complete genome sequence of *L. interrogans*strain \#56601. The chips were hybridized to labelled total DNA extracted from strain Fiocruz L1--130 and ten pathogenic serovars. On the basis of test hybridizations of strain Fiocruz L1--130 vs. the reference sample, we considered genes that gave hybridization ratios between 1.0 and 3.0 to be present in both strains and greater than 10.0 to be absent from the test strain. Ambiguous values between 3.0 and 10.0 may have been due to highly divergent genes or hybridization to paralogous genes. The CGH results revealed that 307 genes of *L. interrogans*strain \#56601 were absent or highly divergent in at least one strain tested. After subtracting these 307 differential genes, we were left with 565 genes, which not only encode presumably surface-exposed proteins but also are conserved in the ten pathogenic serovars.

Transcriptome analysis
----------------------

Microarray analysis of the mRNA extracted from *in vitro*grown leptospires revealed that the fluorescence signals of Cy3 and Cy5 ranged from 10.5 to 51,707 (see Figure [1](#F1){ref-type="fig"}); 1427 genes were expressed above the median level (Cy3 signal ≥ 342 and Cy5 signal ≥ 363.5) in the microarray and therefore as genes with high transcriptional levels. The intersection between the sets of 565 and 1427 genes contained 226 genes. Among them, 8.0% (18/226) were located extracellularly, 53.1% (120/226) in the outer membrane, 16.4% (37/226) in the periplasmic space and 22.6% (51/226) in the inner membrane according to predictions. These vaccine candidates were classified further according their gene names and clusters of orthologous groups (COGs) \[[@B18],[@B19]\](Table [1](#T1){ref-type="table"}, [2](#T2){ref-type="table"}, [3](#T3){ref-type="table"}, [4](#T4){ref-type="table"}); 60.6% (137/226) of the candidates had COG annotations.

Discussion
==========

Vaccines composed of whole cells or outer membrane envelope are available in some countries to prevent human leptospirosis, and clinical trials have been reported \[[@B20]-[@B23]\]. In view of their disadvantages, especially their inability to elicit longer-term protection against different serovars of pathogenic leptospires, efforts have been focused on developing subunit vaccines\[[@B24]\]. During recent years, Hap1\[[@B25]\] (also known as LipL32\[[@B26]\]), LipL41, OmpL1\[[@B27]\] and Lig\[[@B28],[@B29]\] proteins have been identified as promising vaccine candidates for preclinical trials.

The availability of complete genome sequence information for many pathogens and the development of sophisticated computer programs have led to a new paradigm in vaccine development. Now it is possible to screen potential vaccine candidate genes in a reverse manner starting from the genome. This reverse vaccinology was first applied to MenB\[[@B30]\] and is now applied routinely in vaccine development, as in the search for vaccines against *S. pneumoniae, Streptococcus agalactiae, Staphylococcus aureus, Porphyromonas gingivalis, Chlamydia pneumoniae*and other microorganisms\[[@B10]\]. Bioinformatics analysis is the first important strategy of reverse vaccinology. Gram-negative bacteria have five subcellular location sites: cytoplasm, inner membrane, outer membrane, periplasm and extracellular space. The surface-exposed proteins, i.e. those located in sites other than the cytoplasm, are the most suitable vaccine candidates because they are more susceptible to antibody recognition and can therefore elicit protective immune responses. Many sophisticated computer programs have been developed to predict the subcellular locations of putative proteins in the whole genome \[[@B31]-[@B33]\]. Analyzing the gene transcription profile using DNA microarrays provides a second vaccine candidate selection strategy in reverse vaccinology. A gene having a fluorescent signal above the median value corresponds to an expression level higher than 5--10 mRNA copies per genome\[[@B34]\]. Those highly expressed genes could be potential vaccine candidates\[[@B34]\]. Finally, other approaches such as proteomic technology can be used to screen vaccine candidates. Using combined these strategies, genes encoding potential vaccine antigens can eventually be identified.

In our preliminary selection, all genes in *L. interrogans*strain \#56601 were searched using P-CLASSIFIER, a system for predicting the subcellular locations of proteins on the basis of amino acid subalphabets and a combination of multiple support vector machines\[[@B33]\]. Moreover, four topologies were predicted by the corresponding programs. Proteins predicted to be surface-exposed and having any of these four topologies were screened as preliminary vaccine candidates. All proteins with more than four predicted transmembrane spanning regions were removed from the list of candidates, not only because they are likely to be completely embedded in the cell membrane and therefore inaccessible to antibodies, but also because they are difficult to express in *E. coli*\[[@B34]\]. We retained the genes shared by the two sequenced serovars and subtracted genes that had human homologues. The reason we subtracted human homologues is they are likely to cause problems of autoimmunity\[[@B35]\]. Finally, we narrowed the list of vaccine candidates to 616 genes in the genome of *L. interrogans*strain \#56601.

In order to explore vaccine candidates that could generate cross-protection against the diverse serovars of leptospires, we applied CGH to identify genes that are conserved among the ten pathogenic strains involved in most infections\[[@B36]\]. This approach allowed us to refine the vaccine candidate shortlist further by eliminating antigens that were not conserved among these serovars. The 565 vaccine candidates not only presumably surface-exposed but also conserved among the ten prevalent serovars in China were identified as the result of this approach.

Transcriptome analysis was performed using DNA microarrays of *L. interrogans*in order to assess the transcription levels of all genes in the genome. A graph of the signal obtained for each gene gave a diagonal distribution reflecting the expression level of that gene. After subtracting genes with transcriptional levels below the median, we were left with 226 genes as vaccine candidates.

Applying the theory of reverse vaccinology, 226 genes had been identified as potential vaccine candidates against *L. interrogans*combined bioinformatics, CGH and transcriptional analysis. Among them, 60.6% (137/226) have COG annotations; thus, nearly 40% either have an unknown function or have no COG annotation. This group of gene products offers great promise as it comprises a pool of previously unexploited vaccine targets. To evaluate our results, we compared our candidates with those identified by others. Gamberini et al. (2005) found approximately 20% potential surface proteins using *in silico*approach, and sixteen proteins were recognized by antibodies present in human sera\[[@B15]\]. However, only three of them (LA0222, LA2637 and LA2741) appear in our final set. This is not unexpected, since 206 genes encoding hypothetical or unknown proteins were selected from approximately 20% of the genome for cloning and expression. Nally et al. (2005) characterized 32 proteins in outer membrane vesicles of *L. interrogans*serovar Copenhageni by two-dimensional gel electrophoresis, including previously-described outer membrane proteins (OMPs); in addition, unknown, hypothetical and putative OMPs were also identified\[[@B17]\]. Interestingly, only two proteins (LA0222 and LA2637) are represented among the sixteen proteins found by Gamberini and co-workers. There is an overlap of eight genes between our result and that of Nally et al. (2005) (LA0222, LA0505, LA0616, LA1495, LA2024, LA2295, LA2637 and LA3091). The reasons responsible for the discrepancies among the results may be due to differing methodologies. Genomics, transcriptional profiling and proteomics have emerged in the post genomic era with potential to speed up the vaccine discovery research process. It should be pointed out that those methods have their respective advantages and limitations, and can be complementally utilized in the development of the novel vaccines. Genomics involves the use of various softwares to predict sublocalization of proteins. However, some algorithms have limited accuracy. Although transcriptome analysis uses gene chip array to measure gene expression but suffers from the fact that mRNA levels may not reflect protein levels. Expression of a transcribed gene may be regulated at the level of translation. It is believed that the proteome maps of microorganisms are important to understand cellular status at the protein level, which cannot be deciphered from genome or transcriptome analysis\[[@B37]\]. Proteomics of outer membrane can rapidly identify almost all proteins in outer membrane. However, some of the proteins identified in membrane preparations are in fact typical cytoplasmic proteins\[[@B10],[@B38]\]. Moreover, one of the major disadvantages of subproteomic studies by 2-D gel electrophoresis and mass spectrometry is the potential for contamination via leaky fractionation or lysis\[[@B39]\]. Nally et al. (2005) also revealed that outer membrane vesicles contain small amounts of inner membrane or cytoplasmic proteins in their proteomic study\[[@B17]\]. It is worth mentioning here that mainly surface-exposed proteins such as LipL32 (LA2637)\[[@B26],[@B40]\], LipL41 (LA0616)\[[@B27],[@B40]\], LipL45 (LA2295)\[[@B41]\] and LipL21 (LA0011)\[[@B42]\] have higher transcriptional levels in our results; this suggests that the genes with higher transcriptional levels identified in our current research may be preferable for development as vaccine candidates.

This is the first time that CGH and transcription analysis have been used to identify potential candidates for vaccines against *L. interrogans*. Our present work corroborates previous studies, showing the advantages of reverse vaccinology\[[@B8],[@B11]\]. The next step following our present research is to verify whether the selected vaccine candidates are surface-exposed and to evaluate the protective activities of these proteins. Such studies will lead to the development of safe and effective new vaccines against leptospirosis in the future.

Conclusion
==========

We have performed high-throughput *in silico*and microarray-based processes that are useful for determining potential vaccine candidates against leptospirosis. In total, 226 genes were identified in the genome of *L. interrogans*serovar Lai type strain \#56601 using bioinformatics, CGH and transcriptional analysis. The proteins encoded by these genes are not only potentially surface-exposed in the bacterium, but also conserved in two sequenced *L. interrogans*. Moreover, these genes are conserved among ten epidemic serovars in China and have high transcriptional levels *in vitro*. These proteins might therefore be useful for vaccine candidates as well as for the diagnosis of leptospirosis. Further research, including verification that these vaccine candidates are surface-exposed and evaluation their protective activities, will aid in the study of vaccines against leptospirosis in the future.

Methods
=======

Bacteria strains and growth condition
-------------------------------------

Ten strains of *L. interrogans*were used in this study (Table [5](#T5){ref-type="table"}). All the strains were obtained from the Institute for Infectious Disease Control and Prevention (IIDC), Beijing, China. Leptospires were maintained by serial passages in guinea pigs for preservation of virulence and were cultured in liquid Ellinghausen-McCullough-Johnson-Harris (EMJH) medium at 28°C or 37°C with shaking under aerobic conditions. Culture conditions were then developed to ensure that only mid-exponential-phase bacterial cultures at a mean density of 10^6^/ml were used in further experimentation. The cells were harvested by centrifugation at 10,000 *g*for 10 min at 4°C.

The *L. interrogans*serogroup Icterohaemorrhagiae serovar Lai type strain \#56601 (strain Lai) was used to construct the DNA microarray. The genomic DNA of strain Fiocruz L1--130 was kindly provided by the Centro de Pesquisas Goncalo Moniz.

*In silico*analysis
-------------------

Genes and protein data for human and for the sequenced *L. interrogans*(serovar Lai and serovar Copenhageni) were downloaded from NCBI. P-CLASSIFIER\[[@B33]\] was applied to predict the subcellular locations of proteins in *L. interrogans*strain \#56601. Signal peptide prediction was carried out using SignalP 3.0\[[@B43]\]. α-Helix transmembrane topology prediction was carried out using TMHMM\[[@B44]\]. BOMP was used to predict β-barrel outer membrane proteins\[[@B45]\]. Putative lipoproteins were predicted by SpLiP\[[@B46]\]. To identify proteins orthologous between serovar Lai and serovar Copenhageni as well as between serovar Lai and human, all predicted proteins were searched against each other locally using BLASTP\[[@B47]\].

Comparative genomic hybridization
---------------------------------

DNA microarrays of *L. interrogans*strain \#56601 consisting of 3528 annotated ORFs longer than 250bp were prepared as previously described \[[@B48]\]. The genomic DNA of *L. interrogans*strain \#56601 was used for reference in the double-fluorescence hybridization, and the genomic DNA of strain Fiocruz L1--130 was used as a control. A CGH microarray analysis of strain Lai and strain Fiocruz L1--130 was performed first. The qualified threshold determined in this control experiment was used to identify gene deletions in other strains. Reference or test DNA was fluorescently labelled through direct incorporation of Cy3-dCTP or Cy5-dCTP (Amersham Pharmacia Biotech) respectively by a randomly primed polymerization reaction. Unincorporated nucleotides and random primers were removed using QIAquick Nucleotide Removal columns (QIAGEN) according to the manufacturer\'s instructions.

Hybridizations were conducted in a hybridization chamber at 42°C overnight. Slides were washed at 55°C with 1 × SSC containing 0.2% SDS for 10 min and then at 55°C with 0.1 × SSC containing 0.2% SDS for 20 min and finally at room temperature with 0.1 × SSC for 3 min. Competitive hybridization was performed twice for each strain. In the first experiment, *L. interrogans*strain \#56601 reference DNA and the sample DNA were labelled with Cy3 and Cy5, respectively. In the second hybridization, the dyes for labelling were interchanged.

Microarrays were scanned using a Chipreader laser scanner GenePix 4000B AXON (Axon Instruments, Union City, CA) according to the manufacturer\'s recommendations. Spot quantification, signal normalization and data visualization were performed using the programs GeneSpring 5.0.2 (Silicon Genetics) and Microsoft Excel.

Transcriptome analysis
----------------------

*L. interrogans*was grown in EMJH medium at 37°C under aerobic conditions for transcriptome analysis. Only mid-log-phase cultures at a mean density of 10^6^/ml in 100 ml were used in transcriptional experiments.

Total RNA was isolated from leptospires using Trizol reagent (Invitrogen) according to the manufacturer\'s protocol. Contaminating DNA was digested with RQ1 RNase-free DNase (Promega Corp.). The treated RNA was purified with a QIAGEN RNeasy Kit (QIAGEN).

RNA (10 μg) was labelled with Cy3 by reverse transcription using Superscript α (Invitrogen). Unincorporated dye was removed using a QIAquick Nucleotide Removal Kit (QIAGEN) as specified in the manufacturer\'s protocol. Samples were hybridized under cover slides to the microarray slides overnight at 42°C, and then washed as usual. The hybridization slides were processed by Tiffsplit (Agilent) and data were further analyzed using Genespring software 5.0.2 and normalized using mean values combined with Microsoft Excel software. Microarrays were used to assay relative RNA abundance. Flagged spots or SN\<2 spots were excluded for intrachip and interchip reproducibility analysis. We calculated the coefficients of three spots in same chip for each gene to estimate intrachip reproducibility using Microsoft Excel. The signal values from the experiments represent average mRNA abundances. As in the CGH experiments, the dyes for labelling Cy3 and Cy5 were interchanged in the second hybridization.

Figure [2](#F2){ref-type="fig"} is a scheme of the procedure we used to identify the vaccine candidates as described above (the numbers in parentheses are the results after the corresponding procedure step).

Authors\' contributions
=======================

HLY and XKG designed the research project. HLY and YZZ carried out the bioinformatics analysis. PH and HLY completed the CGH. JHQ and HLY coordinated the transcriptome analysis. HLY and XKG drafted the manuscript. XCJ and GPZ participated in the design of the study and helped to draft the manuscript. All authors contributed to the writing and preparation of the manuscript. All authors read and approved the final manuscript.

Acknowledgements
================

We thank Bao-Yu Hu and Yang Yang (Department of Microbiology and Parasitology, Shanghai Jiao Tong University School of Medicine) for help in bacterial culture preparation. This work was supported in part by grants from the National Natural Science Foundation of China (No.30370071 & 30670102), the National High Technology Research and Development Program of China and Shanghai Leading Academic Discipline Project (T0206). Moreover, we are grateful to the editors and anonymous reviewers for thoughtful comments on the manuscript.

Figures and Tables
==================

![Identification of highly expressed genes in *L. interrogans*by microarray. Bacteria were grown in EMJH medium at 37°C and were collected when the culture reached mid-exponential-phase. RNA was purified and labelled with either Cy3 or Cy5 and hybridized with the microarray of *L. interrogans*strain \#56601 (3528 genes). Transcription analysis revealed that 1427 genes were highly expressed (cy3 signal ≥ 342 and cy5 signal ≥ 363.5).](1471-2164-7-293-1){#F1}
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###### 

The result of vaccine candidates according to localization sites: extracellular

  gene     Cy3 signal   Cy5 signal   COG                 product
  -------- ------------ ------------ ------------------- --------------------------------
  LA0074   402.2        574.7        \-                  hypothetical protein
  LA0322   1,118        760.5        \-                  hypothetical protein
  LA0444   1,699        1,024        COG1196D COG4254S   hypothetical protein
  LA0587   3,246        2,998        COG1075R            Lactonizing lipase
  LA0617   672          487.5        \-                  hypothetical protein
  LA1433   1,946        1,552        \-                  hypothetical protein
  LA1508   559.2        853          \-                  putative outermembrane protein
  LA1569   755.3        391.3        COG5651N            putative lipoprotein
  LA2471   354.5        572.5        COG0457R            putative outermembrane protein
  LA2823   1,466        884          \-                  putative lipoprotein
  LA2975   478.8        454.2        \-                  hypothetical protein
  LA2992   663.8        535.3        COG0419L            hypothetical protein
  LA3210   410.7        847.7        \-                  hypothetical protein
  LA3338   899.8        795.8        \-                  putative lipoprotein
  LA3394   392.3        652          \-                  hypothetical protein
  LA3779   374.8        431.7        \-                  hypothetical protein
  LA3848   395.5        368.8        \-                  putative lipoprotein
  LB225    798          1,069        \-                  hypothetical protein

###### 

The result of vaccine candidates according to localization sites: outermembrane

  gene     Cy3 signal   Cy5 signal   COG                                      product
  -------- ------------ ------------ ---------------------------------------- --------------------------------------------------------------------------
  LA0049   471          478.2        COG0840NT COG2202T                       aerotaxis sensor receptor, flavoprotein
  LA0099   1,081        853.5        \-                                       hypothetical protein
  LA0166   2,149        1,113        COG1196D                                 hypothetical protein
  LA0178   1,224        953.8        COG0706U                                 60Kd inner membrane protein
  LA0241   554.5        905.7        COG1999R                                 SCO1/SenC family protein
  LA0253   755.8        559.2        COG2849S                                 hypothetical protein
  LA0272   462.2        734.8        \-                                       hypothetical protein
  LA0301   787          771.8        COG2885M                                 outer membrane protein OmpA family
  LA0330   554          397.3        COG2366R                                 Penicillin G acylase precursor
  LA0339   1,060        1,185        COG0584C                                 Glycerophosphoryl diester phosphodiesterase
  LA0365   1,290        1,959        \-                                       hypothetical protein
  LA0370   720.7        952.8        \-                                       hypothetical protein
  LA0378   692.5        560.3        COG0457R                                 TPR-repeat-containing proteins
  LA0379   1,134        957          \-                                       hypothetical protein
  LA0410   3,451        3,604        COG2834M                                 hypothetical protein
  LA0423   553          712.8        COG2931Q                                 hypothetical protein
  LA0505   6,317        7,727        COG1409R                                 probable glycosyl hydrolase
  LA0532   736.5        684.7        \-                                       hypothetical protein
  LA0568   434.8        435.3        COG2067I                                 hypothetical protein
  LA0635   1,131        712.8        \-                                       S-layer-like array protein
  LA0678   973.3        952.5        COG0840NT                                Methyl-accepting chemotaxis protein mcpB
  LA0811   478.8        770.5        \-                                       hypothetical protein
  LA0818   481.3        946.8        \-                                       hypothetical protein
  LA0878   886.7        555.7        COG0266L                                 DshA protein
  LA0940   1,467        1,026        \-                                       hypothetical protein
  LA0957   2,798        1,542        COG1538MU                                outer membrane efflux protein
  LA1009   764.8        887.7        COG5009M                                 Penicillin-binding protein 1A
  LA1010   1,124        829          \-                                       putative outermembrane protein
  LA1087   376.5        536          \-                                       hypothetical protein
  LA1099   2,388        1,500        COG3103T                                 hypothetical protein
  LA1100   2,901        2,796        COG1538MU                                outer membrane efflux protein
  LA1161   474.2        403          COG2067I                                 long-chain fatty acid transport protein
  LA1174   615          423          COG0834ET                                amino acid ABC transporter, periplasmic amino acid-binding protein
  LA1192   616.3        545.3        \-                                       putative outermembrane protein
  LA1404   1,377        977          \-                                       putative outermembrane protein
  LA1412   1,034        640.3        \-                                       hypothetical protein
  LA1495   1,920        2,172        \-                                       putative outermembrane protein
  LA1501   558.2        545.7        COG4775M COG5009M                        hypothetical protein
  LA1507   1,615        1,747        \-                                       hypothetical protein
  LA1690   744.7        471.7        COG0449M                                 hypothetical protein
  LA1733   1,418        1,557        \-                                       hypothetical protein
  LA1912   873.8        745          \-                                       putative outermembrane protein
  LA1917   595.5        535.3        \-                                       hypothetical protein
  LA1931   941.5        1,540        \-                                       putative outermembrane protein
  LA1987   909.3        994.5        \-                                       putative outermembrane protein
  LA1996   556.8        674          \-                                       hypothetical protein
  LA2024   2,594        2,079        \-                                       hypothetical protein
  LA2063   1,463        1,967        \-                                       hypothetical protein
  LA2094   548.2        380.3        COG1716T                                 FHA-domain containing protein
  LA2126   1,223        979.7        COG0616OU                                Putative signal peptide peptidase sppA
  LA2215   1,045        679.2        COG1196D COG1360N                        Chemotaxis motB protein
  LA2238   420          464.7        COG0726G                                 polysaccharide deacetylase
  LA2266   367.3        364.5        \-                                       putative outermembrane protein
  LA2267   886.2        1,542        COG0457R                                 putative outermembrane protein
  LA2268   971.7        1,074        \-                                       putative outermembrane protein
  LA2295   4,445        6,689        COG0532J COG4254S                        LipL45 protein
  LA2318   813.2        673.8        COG4775M                                 Predicted outer membrane protein
  LA2368   347.8        585          COG1555L COG3156U COG0477GEPR COG0075E   type II secretion pathway related protein etpK-like protein
  LA2375   1,255        2,047        COG1450NU                                General secretory pathway protein D
  LA2377   377.5        418          COG0739M                                 peptidase, M23/M37 family protein
  LA2395   847.3        1,736        COG2815S                                 putative outermembrane protein
  LA2413   540.7        381.2        COG0791M                                 Probable lipoprotein nlpC precursor
  LA2464   362          435.7        COG3225N                                 gliding motility protein GldG
  LA2468   3,653        6,205        COG1196D                                 hypothetical protein
  LA2510   1,230        846          COG1452M                                 hypothetical protein
  LA2537   1,329        1,304        \-                                       hypothetical protein
  LA2538   624.2        606.5        \-                                       hypothetical protein
  LA2612   532.8        574          COG3190N                                 flagellar protein required for flagellar formation
  LA2617   656.5        697.8        \-                                       hypothetical protein
  LA2656   1,128        637.2        COG2968S                                 hypothetical protein
  LA2664   905.3        867.8        COG1706N                                 flagellar P-ring protein precursor
  LA2672   662.3        1,116        \-                                       hypothetical protein
  LA2741   1,649        916.7        \-                                       hypothetical protein
  LA2742   814.8        524.2        \-                                       hypothetical protein
  LA2755   4,175        2,808        COG0768M                                 probable penicillin-binding protein
  LA2757   1,213        1,270        COG1792M                                 rod shape-determining protein mreC
  LA2800   665          1,591        \-                                       hypothetical protein
  LA2818   681.7        440.8        \-                                       hypothetical protein
  LA2857   506.7        516.5        COG0596R                                 Predicted hydrolase or acyltransferase, alpha/beta hydrolase superfamily
  LA2949   407.5        460          COG0265O                                 heat shock protein, HtrA1
  LA3069   1,221        786.3        \-                                       hypothetical protein
  LA3091   995.5        879.7        \-                                       hypothetical protein
  LA3118   771.7        1,239        COG0466O                                 hypothetical protein
  LA3149   608.3        421.8        COG1629P                                 Hemin receptor
  LA3165   749.2        454.7        COG4642S                                 conserved hypothetical protein with MORN repeat
  LA3353   432.2        698.2        \-                                       hypothetical protein
  LA3403   391.3        388.8        \-                                       hypothetical protein
  LA3434   724.7        625.7        COG0860M                                 N-acetylmuramoyl-L-alanine amidase
  LA3440   915.5        864.3        COG0237H                                 hypothetical protein
  LA3468   618          584.8        COG1629P                                 probable TonB-dependent receptor
  LA3469   658.2        685.7        COG3487P                                 iron-reglulated protein A
  LA3506   1,407        1,266        COG0840NT                                Methyl-accepting chemotaxis protein
  LA3552   1,652        2,900        \-                                       hypothetical protein
  LA3632   1,028        1,337        COG1413C                                 PBS lyase HEAT-like repeat containing protein
  LA3681   463.5        459          \-                                       phage-related-like protein
  LA3744   1,318        840.2        \-                                       hypothetical protein
  LA3862   537.3        761.3        COG0532J                                 hypothetical protein
  LA3872   385.3        648.8        COG0616OU                                Putative signal peptide peptidase sppA
  LA3938   589          1,026        COG0457R                                 hypothetical protein
  LA3970   532.7        398.5        \-                                       hypothetical protein
  LA4070   9,764        5,630        \-                                       hypothetical protein
  LA4212   1,678        1,684        \-                                       hypothetical protein
  LA4227   2,465        1,953        COG5621R                                 hypothetical protein
  LA4232   509.3        612.2        COG2982M                                 hypothetical protein
  LA4261   485.7        612.5        COG0451MG                                UDP-glucose 4-epimerase
  LA4263   1,012        1,290        \-                                       hypothetical protein
  LA4285   726.3        791.2        COG3858R                                 hypothetical protein
  LA4341   1,009        1,146        COG0739M                                 Peptidase family M23/M37
  LB018    1,549        1,589        COG1635H                                 hypothetical protein
  LB025    371.8        382.5        \-                                       hypothetical protein
  LB050    344          533.3        \-                                       hypothetical protein
  LB056    443.5        523.8        COG0457R                                 TPR-repeat-containing protein
  LB061    550.2        769.7        COG3211R                                 hypothetical protein
  LB191    344.3        410          COG1629P COG4771P                        putative TonB-dependent outer membrane receptor protein
  LB199    917.3        925.2        COG1629P                                 putative outermembrane protein
  LB258    552.5        1,082        COG4870O                                 Cysteine protease
  LB277    1,634        984.3        \-                                       hypothetical protein
  LB279    1,115        804.3        COG1629P                                 hypothetical protein
  LB328    1,591        2,672        COG1360N COG2885M                        outer membrane protein OmpA
  LB362    1,246        7,69         \-                                       hypothetical protein

###### 

The result of vaccine candidates according to localization sites: periplasmic

  gene     Cy3 signal   Cy5 signal   COG         product
  -------- ------------ ------------ ----------- -------------------------------------------------
  LA0430   2,614        2,094        COG1830G    hypothetical protein
  LA0011   1472.2       2164         \-          putative lipoprotein
  LA0093   963.2        539.3        \-          hypothetical protein
  LA0107   476          466.3        \-          hypothetical protein
  LA0222   9,873        18,863       COG2885M    outer membrane protein OmpA family
  LA0312   526.2        366.7        COG0739M    M23/M37 family protein
  LA0413   505.3        544.2        \-          hypothetical protein
  LA0494   551          1,165        \-          hypothetical protein
  LA0569   404.2        366.3        \-          hypothetical protein
  LA0616   8,877        7,462        COG0457R    outer membrane lipoprotein lipL41
  LA1118   610.2        614.3        \-          putative outermembrane protein
  LA1136   636.5        1,301        COG2834M    hypothetical protein
  LA1155   534.3        563.8        COG1613P    sulfate-binding protein precursor
  LA1312   1,514        1,070        \-          hypothetical protein
  LA1448   1,090        1,857        COG1464P    putative outermembrane protein
  LA1998   676          700.8        COG0726G    polysaccharide deacetylase
  LA2023   622          405          COG2010C    cytochrome c
  LA2208   2,252        2,334        COG3858R    hypothetical protein
  LA2277   609.5        391.3        \-          hypothetical protein
  LA2316   633.3        707.2        \-          putative outermembrane protein
  LA2372   1,427        2,257        COG2165NU   General secretory pathway protein G
  LA2531   1,177        894.5        COG1196D    hypothetical protein
  LA2637   51,707       37,602       \-          LipL32 protein
  LA2748   714.5        537.3        COG1613P    Sulfate-binding protein precursor
  LA2820   691.3        525.5        \-          hypothetical protein
  LA2950   373.8        661          COG0265O    HtrA2
  LA2993   349          433.8        \-          hypothetical protein
  LA3507   1,360        721.7        COG2010C    putative cytochrome c
  LA3535   541.2        659.8        \-          hypothetical protein
  LA3571   607.2        492.8        COG2010C    putative cytochrome c
  LA3576   595.8        594.5        COG1360N    flagellar motor protein
  LA3780   1,365        1,432        \-          hypothetical protein
  LA3839   664          618.3        COG1881R    Phosphatidylethanolamine-binding family protein
  LA3944   507.3        595.2        \-          hypothetical protein
  LA4262   355          515.8        \-          hypothetical protein
  LB047    506.3        2,137        COG2849S    hypothetical protein
  LB098    735.5        507.3        COG0726G    Predicted xylanase/chitin deacetilase

###### 

The result of vaccine candidates according to localization sites: innermembrane

  gene     Cy3 signal   Cy5 signal   COG                    product
  -------- ------------ ------------ ---------------------- -------------------------------------------------------------
  LA0238   662.5        433.2        COG1612O               cytochrome-c oxidase assembly factor ctaA
  LA0250   651.2        738.8        COG4956R               TRAM family protein
  LA0314   577.2        368          COG0168P               Trk system potassium uptake protein trkH
  LA0550   1,353        886.5        COG0841V               NolG efflux transporter
  LA0639   858.2        469.7        \-                     hypothetical protein
  LA0650   870.7        628          COG0705R               Rhomboid family protein
  LA0680   530.2        707.5        COG0004P               hypothetical protein
  LA0960   760.7        452          \-                     hypothetical protein
  LA1056   702.7        607.8        COG0840NT              hypothetical protein
  LA1143   4,027        4,074        COG0341U               Preprotein translocase subunit SecF
  LA1191   1,014        790.7        COG0840NT              Methyl-accepting chemotaxis protein
  LA1283   902.2        1,162        COG0845M               hypothetical protein
  LA1284   415.7        543          COG4591M               Lipoprotein releasing system transmembrane protein lolC
  LA1321   374.8        860.8        COG4232OC              thiol:disulfide interchange protein DsbD
  LA1397   722.8        672.3        COG1033R               putative Protein export membrane protein SecD/SecF
  LA1435   612.2        524.3        COG0392S               hypothetical protein
  LA1451   415.2        435.2        COG1183I               Phosphatidylglycerophosphate synthase
  LA1471   3,360        7,809        COG3808C               Pyrophosphate-energized vacuolar membrane proton pump
  LA1477   566.7        436.8        COG1519M               3-deoxy-D-manno-octulosonic-acid transferase
  LA1535   521.5        685.5        \-                     hypothetical protein
  LA1554   498.7        398.2        COG1502I               hypothetical protein
  LA1695   4,493        2,360        \-                     CrcB-like protein
  LA1958   2,663        1,551        COG0526OC              putative outermembrane protein
  LA1979   483.8        657.8        COG0463M               Putative glycosyl transferase
  LA1982   342.5        452          COG3307M               hypothetical protein
  LA2050   411.3        848.8        COG0707M               UDP-N-acetylglucosamine:LPS N-acetylglucosamine transferase
  LA2250   10,742       9,624        \-                     Nuclease S1
  LA2275   1,415        1,071        COG0586S               dedA protein
  LA2320   1,319        1,496        COG0811U               biopolymer transport protein, putative
  LA2604   464.3        448.7        \-                     hypothetical protein
  LA2737   3,813        2,157        COG0204I               putative acyltransferase
  LA2891   5,229        3,140        COG1055P               hypothetical protein
  LA3072   1,970        1,665        COG0477GEPR            hypothetical protein
  LA3110   1,262        2,371        COG2156P               potassium-transporting ATPase, C chain
  LA3146   877          523.2        COG2076P               hypothetical protein
  LA3577   1,618        1,198        COG1291N               motility protein A
  LA3586   2,348        1,746        COG4270S               hypothetical protein
  LA3754   667.3        449.7        COG0681U               Signal peptidase I
  LA3777   497.3        539          COG0239D               Protein crcB homolog
  LA3806   2,116        2,869        COG0004P               Probable ammonium transporter
  LA3916   5,518        5,510        \-                     hypothetical protein
  LA3926   967.8        1,802        COG0841V               transmembrane efflux pump protein
  LA4062   1,326        2,138        \-                     hypothetical protein
  LA4154   638.7        759          COG3225N               hypothetical protein
  LA4155   1,140        1,015        COG1277R               probable permease of ABC transporter
  LA4172   411          392.5        \-                     hypothetical protein
  LA4228   559.5        627.8        COG4174R               Dipeptide transport system permease protein dppB
  LA4233   409          985.7        COG1172G               hypothetical protein
  LA4269   1,907        2,240        COG2207K COG0477GEPR   transcriptional regulator, AraC family
  LB174    2,150        3,440        COG0501O               heat shock protein HtpX
  LB281    5,026        2,708        COG0811U               transport protein ExbB

###### 

Bacterial strains used in the study

  serogroup             serovar      strain
  --------------------- ------------ ------------
  Icterohaemorrhagiae   Lai          Lai(56601)
  Canicola              Canicola     Lin
  Pyrogenes             Pyrogenes    4
  Autumnalis            Autumnalis   Lin 4
  Australis             Australis    65-9
  Pomona                Pomona       Luo
  Grippotyphosa         Linhai       Lin 6
  Hebdomadis            Hebdomadis   P 7
  Bataviae              Paidjan      L 37
  Sejroe                Wolffi       L 183
